Literature DB >> 11096460

Regulation of interleukin-8 expression by cellular pH in human pancreatic adenocarcinoma cells.

Q Shi1, X Le, B Wang, Q Xiong, J L Abbruzzese, K Xie.   

Abstract

The role of cellular pH in the expression and regulation of interleukin-8 (IL-8) in human tumor cell lines was determined. Transient exposure to pH ranging from 7.4 to 6.7 induced pH-dependent expression of IL-8 at both the mRNA and protein levels in three different human tumor cell lines, including COLO357 pancreatic adenocarcinoma cells, SW620 colon adenocarcinoma cells, and PC3 prostate adenocarcinoma cells. Investigation of the mechanisms of IL-8 induction in response to acidosis was carried out using the COLO357 human pancreatic cancer cell line. The increased steady-state level of mRNA correlated with an increased transcription rate and stability of IL-8 transcripts. Further experiments indicated that mild acidosis activated the transcription factors NF-kappaB and AP-1 and that the cooperation of these two factors appeared to be essential to the transactivation of the IL-8 gene. Our data demonstrated that low tumor pH contributes to the enhanced expression of IL-8 and plays an important role in tumor progression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11096460     DOI: 10.1089/10799900050198471

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  20 in total

Review 1.  Mouse models of metastatic pancreatic adenocarcinoma.

Authors:  K Xie; B Wang; Q Shi; J L Abbruzzese; Q Xiong; X Le
Journal:  Int J Pancreatol       Date:  2001

Review 2.  The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis.

Authors:  Daniel J Brat; Anita C Bellail; Erwin G Van Meir
Journal:  Neuro Oncol       Date:  2005-04       Impact factor: 12.300

Review 3.  Metabolic changes associated with tumor metastasis, part 1: tumor pH, glycolysis and the pentose phosphate pathway.

Authors:  Valéry L Payen; Paolo E Porporato; Bjorn Baselet; Pierre Sonveaux
Journal:  Cell Mol Life Sci       Date:  2015-12-01       Impact factor: 9.261

Review 4.  Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies.

Authors:  Kristin G Anderson; Ingunn M Stromnes; Philip D Greenberg
Journal:  Cancer Cell       Date:  2017-03-13       Impact factor: 31.743

5.  Helicobacter pylori environmental interactions: effect of acidic conditions on H. pylori-induced gastric mucosal interleukin-8 production.

Authors:  Il Ju Choi; Saori Fujimoto; Kazuyoshi Yamauchi; David Y Graham; Yoshio Yamaoka
Journal:  Cell Microbiol       Date:  2007-05-21       Impact factor: 3.715

6.  Interleukin-8 increases vascular endothelial growth factor and neuropilin expression and stimulates ERK activation in human pancreatic cancer.

Authors:  Min Li; Yuqing Zhang; Louis W Feurino; Hao Wang; William E Fisher; F Charles Brunicardi; Changyi Chen; Qizhi Yao
Journal:  Cancer Sci       Date:  2008-02-27       Impact factor: 6.716

Review 7.  Experimental animal models of pancreatic carcinogenesis and metastasis.

Authors:  Daoyan Wei; Henry Q Xiong; James L Abbruzzese; Keping Xie
Journal:  Int J Gastrointest Cancer       Date:  2003

8.  Hypercapnia induces cleavage and nuclear localization of RelB protein, giving insight into CO2 sensing and signaling.

Authors:  Kathryn M Oliver; Colin R Lenihan; Ulrike Bruning; Alex Cheong; John G Laffey; Paul McLoughlin; Cormac T Taylor; Eoin P Cummins
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

9.  Acidosis promotes invasiveness of breast cancer cells through ROS-AKT-NF-κB pathway.

Authors:  Subash C Gupta; Ramesh Singh; Radhika Pochampally; Kounosuke Watabe; Yin-Yuan Mo
Journal:  Oncotarget       Date:  2014-12-15

10.  Extracellular acidosis stimulates NHE2 expression through activation of transcription factor Egr-1 in the intestinal epithelial cells.

Authors:  Saminathan Muthusamy; Ming Cheng; Jong-Jin Jeong; Anoop Kumar; Pradeep K Dudeja; Jaleh Malakooti
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.